Abstract:: Self-reported smoking is often incorporated into disease prediction tools but suffers from recall bias and does not capture passive exposure. Blood-based DNA methylation (DNAm) is an objective way to assess smoking. However, studies have not fully explored tissue-specificity or epigenome-wide coverage beyond array data. Here, we update the existing biomarkers of smoking and conduct a detailed analysis of the associations between blood DNAm and self-reported smoking. : A blood-based Bayesian epigenome-wide association study (EWAS) of smoking was carried out in 17,865 Generation Scotland individuals at ~850k CpG sites (Illumina EPIC array). For 24 pairs of smokers and non-smokers a high-resolution approach was implemented (~4 million sites, TWIST methylome panel). A DNAm-derived biomarker of smoking (mCigarette) was tested in the independent Lothian Birth Cohort 1936 (n=882, Illumina 450k array) and in the ALSPAC parents and offspring at four time points (range n=496-1,207). To explore tissue specific signals, EWASs of smoking were run across five brain regions for 14 individuals using DNAm from the EPIC array. Lastly, genome-wide association studies (GWASs) of smoking pack years and an epigenetic score for smoking (GrimAge DNAm pack years) were conducted (n=17,105). The primary EWAS analyses identified two novel genome-wide significant loci, mapping to genes related to addiction and carcinogenesis. Associations with CpG sites which are currently absent from methylation arrays were identified by the high resolution EWAS of smoking (n=48). The mCigarette pack years biomarker showed excellent discrimination across all smoking categories (current, former, never), and outperformed existing predictors in associations with pack years in an external test dataset (Pearson r=0.75). Several CpGs showed near-perfect discrimination of smoking status in both blood and brain, but these loci did not overlap across tissues. The GWAS of DNAm (but not self-reported) pack years identified novel and established smoking-related loci. However, the self-reported phenotype GWAS had a higher genetic correlation with a large meta-analysis GWAS of self-reported pack years. Among the study shortcomings are its potential lack of generalizability to non-Europeans and the absence of serum cotinine data. : A multi-tissue, multi-cohort analysis of the relationship between smoking, DNA and DNAm (assessed via arrays and targeted sequencing) has improved our understanding of the biological consequences of smoking.

Polygenic risk scores for nicotine use and family history of smoking are associated with smoking behaviour

Multiple Independent Loci at Chromosome 15q25.1 Affect Smoking Quantity: a Meta-Analysis and Comparison with Lung Cancer and COPD.

Blood- and brain-based genome-wide association studies of smoking

Associations of genetic risk and smoking with incident COPD

Interaction Between Continuous Pack-Years Smoked And Polygenic Risk Score On Lung Cancer Risk: Prospective Results From The Framingham Heart Study

Rare genetic variants explain missing heritability in smoking

Genome-wide Interaction Study of Smoking Behavior and Non-Small Cell Lung Cancer Risk in Caucasian Population

Dissecting the genetic overlap of smoking behaviors, lung cancer, and chronic obstructive pulmonary disease: A focus on nicotinic receptors and nicotine metabolizing enzyme

Genome-wide Association Studies for Identifying Genetic Architecture of SGRQ in Smoking Population

Pleiotropy of Genetic Variants on Obesity and Smoking Phenotypes: Results from the Oncoarray Project of the International Lung Cancer Consortium

Increased genetic vulnerability to smoking at CHRNA5 in early-onset smokers.

Association studies of up to 1.2 million individuals yield new insights into the genetic etiology of tobacco and alcohol use

Association of smoking and polygenic risk with the incidence of lung cancer: a prospective cohort study

Conditional and Unconditional Genome-Wide Association Study Reveal Complicate Genetic Architecture of Human Body Weight and Impacts of Smoking

Prediction of Smoking Behavior From Single Nucleotide Polymorphisms With Machine Learning Approaches

Neurogenetic underpinnings of nicotine use severity: Integrating the brain transcriptomes and GWAS variants via network approaches

Polygenic scores for tobacco use provide insights into systemic health risks in a diverse EHR-linked biobank in Los Angeles

Large-scale genome-wide association study of Asian population reveals genetic factors in FRMD4A and other loci influencing smoking initiation and nicotine dependence

Genome-wide Interaction Study with Smoking for Colorectal Cancer Risk Identifies Novel Genetic Loci Related to Tumor Suppression, Inflammation, and Immune Response

Dopamine Genes and Nicotine Dependence in Treatment Seeking and Community Smokers

Loci on Chromosome 20 Interact with rs16969968 to Influence Cigarettes per Day in European Ancestry Individuals